Daniel H Schneiderman's Net Worth
$0
Who is Daniel H Schneiderman?
Daniel H Schneiderman does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include MetaStat, Inc., First Wave BioPharma, Inc., and Pasithea Therapeutics Corp..
SEC CIK
Daniel H Schneiderman's CIK is 0001565536
Past Insider Trading and Trends
2020 was Daniel H Schneiderman's most active year for acquiring shares with 3 total transactions. Daniel H Schneiderman's most active month to acquire stocks was the month of December. 2021 was Daniel H Schneiderman's most active year for disposing of shares, totalling 2 transactions. Daniel H Schneiderman's most active month to dispose stocks was the month of May. 2018 saw Daniel H Schneiderman paying a total of $71,574.66 for 76,962 shares, this is the most they've acquired in one year. In 2017 Daniel H Schneiderman cashed out on 25,000 shares for a total of $75,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MetaStat, Inc. No price found
VP OF FINANCE AND SECRETARY
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
| +5.59% | 20K |
—
|
—
| 377.5K |
Oct 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
First Wave BioPharma, Inc. (FWBI) Snapshot price: $5.5
CHIEF FINANCIAL OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Pasithea Therapeutics Corp. (KTTA) Snapshot price: $6.03
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||